Luca Roncati, Italian pathologist, physician-scientist, anti-cancer patent inventor, academic editor, medical lecturer, and award-winning author with more than 250 publications to his credit, specialized in gynecologic oncology, pediatric pathology, hematopathology and soft tissue tumors, eponym of Roncati-Manenti triad, describer of T rex lymphoma, pioneering researcher in COVID-19, leading researcher in nanopathology, forensics expert and adjunct professor of anatomical pathology at the University of Modena and Reggio Emilia (Italy).

Melanoma; Non-melanoma skin cancer; Cutaneous lymphoma; Surgical pathology; Oncology; Gynecologic pathology; Gynecologic oncology; Breast cancer; Hematopathology; Dermatopathology; Nanopathology; Oncohematology; Epstein-Barr virus (EBV); Kaposi's sarcoma-associated herpesvirus (HHV8); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Human papilloma virus (HPV); HPV test; PAP smear; Anatomical pathology; Forensic sciences.